Log In
Print this Print this

Avage, tazarotene

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionTopical cream formulation of 0.1% tazarotene, a retinoid prodrug
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today